"Designing Growth Strategies is in our DNA"

U.S. Biosimilars Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Filgrastim & Pegfilgrastim, Monoclonal Antibodies, and Others), By Disease Indication (Cancer, Autoimmune Diseases {Arthritis, Psoriasis, Neutropenia, and Others}, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2022-2029

Region : United States | Format: PDF | Report ID: FBI100990

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Key Diseases (Arthritis, Psoriasis, Neutropenia, Cancer), in the U.S.
    2. Pipeline Analysis, Key Players
    3. Regulatory Scenario
    4. Key Industry Developments - Partnerships, Mergers & Acquisitions
    5. Impact of COVID-19 on the Biosimilars Market
  5. U.S. Biosimilars Market Analysis, Insights and Forecast, 2018-2029
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Filgrastim & Pegfilgrastim
      2. Monoclonal Antibodies
      3. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Cancer
      2. Autoimmune Diseases
        1. Arthritis
        2. Psoriasis
        3. Neutropenia
        4. Others
      3. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2021)
    2. Profiles of Players Operating in the Market (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (based on availability))
      1. Celltrion Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)
      2. Pfizer Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)
      3. Novartis AG
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)
      4. Amgen Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)
      5. Viatris Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)
      6. Coherus BioSciences
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)     
      7. Samsung Bioepis
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)
      8. Other Players
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (based on availability)
  7. Strategic Recommendations
Read Less

Table 01: U.S. Biosimilars Market Revenue (USD billion) Forecast, by Drug Class, 2018-2029

Table 02: U.S. Biosimilars Market Revenue (USD billion) Forecast, by Disease Indication, 2018-2029

Table 03: U.S. Biosimilars Market Revenue (USD billion) Forecast, by Autoimmune Diseases, 2018-2029

Table 04: U.S. Biosimilars Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

 class=
  • May, 2022
  • 2021
  • 2018-2020
  • 105

    CHOOSE LICENSE TYPE

  • $2850
    $3850
    $5850
    Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X